Income Taxes (Details Textual) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Apr. 02, 2022 |
Apr. 03, 2021 |
|
| Income Tax Contingency [Line Items] | ||
| Provision of Income Tax | 22.40% | 23.20% |
| Unrecognized tax benefit | $ 9,710 | |
| Unrecognized tax benefits that would impact effective tax rate | $ 2,289 | |
| Federal returns currently under examination | The Company remains subject to income tax examinations in the U.S. and various state and foreign jurisdictions for tax years 2009-2019. Although the Company is not currently under examination in most jurisdictions, limited transfer pricing disputes exist for years dating back to 2008. The Company estimates a net benefit ranging from $0 to $207 could be recognized within the next 12 months due to the expiration of statutes of limitation. | |
| Transfer Pricing Dispute Resolution [Member] | Minimum [Member] | ||
| Income Tax Contingency [Line Items] | ||
| Unrecognized tax benefit | $ 0 | |
| Transfer Pricing Dispute Resolution [Member] | Maximum [Member] | ||
| Income Tax Contingency [Line Items] | ||
| Unrecognized tax benefit | $ 207 | |
| X | ||||||||||
- Definition Effective interest of provision of income tax. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of unrecognized tax benefits. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|